EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

ACAD10 is not required for metformin's metabolic actions or for maintenance of whole‐body metabolism in C57BL / 6J mice

Michael J Yew, Sarah E Heywood, Joe Ng, Olivia M West, Martin Pal, Andrew Kueh, Graeme I Lancaster, Stephen Myers, Christine Yang, Yingying Liu, Saskia Reibe, Natalie A Mellett und 5 weitere

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Michael J Yew und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, The University of Tasmania, Launceston, Tasmania, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metformin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shine on Foundation, Diabetes Australia Research Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Acyl‐coenzyme A dehydrogenase family member 10 (ACAD10) is a mitochondrial protein purported to be involved in the fatty acid oxidation pathway. Metformin is the most prescribed therapy for type 2 diabetes; however, its precise mechanisms of action(s) are still being uncovered. Upregulation of ACAD10 is a requirement for metformin's ability to inhibit growth in cancer cells and extend lifespan in Caenorhabditis elegans . However, it is unknown whether ACAD10 plays a role in metformin's metabolic actions. Materials and Methods We assessed the role for ACAD10 on whole‐body metabolism and metformin action by generating ACAD10KO mice on a C57BL/6J background via CRISPR‐Cas9 technology. In‐depth metabolic phenotyping was conducted in both sexes on a normal chow and high fat‐high sucrose diet.

Results

Compared with wildtype mice, we detected no difference in body composition, energy expenditure or glucose tolerance in male or female ACAD10KO mice, on a chow diet or high‐fat, high‐sucrose diet ( p ≥ .05). Hepatic mitochondrial function and insulin signalling was not different between genotypes under basal or insulin‐stimulated conditions ( p ≥ .05). Glucose excursions following acute administration of metformin before a glucose tolerance test were not different between genotypes nor was body composition or energy expenditure altered after 4 weeks of daily metformin treatment ( p ≥ .05). Despite the lack of a metabolic phenotype, liver lipidomic analysis suggests ACAD10 depletion influences the abundance of specific ceramide species containing very long chain fatty acids, while metformin treatment altered clusters of cholesterol ester, plasmalogen, phosphatidylcholine and ceramide species.

Conclusions

Loss of ACAD10 does not alter whole‐body metabolism or impact the acute or chronic metabolic actions of metformin in this model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2MetforminMaleFemaleMiceAnimalsMice, Inbred C57BLGlucoseInsulinCeramidesSucroseDiet, High-Fat

Stichwörter der Autor:innen

ACAD10adiposityglucose tolerancelipidomicsmetforminmitochondria

Substanzen

MetforminGlucoseInsulinCeramidesSucrose

Autor:innen und Institutionen

  • School of Health Sciences, The University of Tasmania, Launceston, Tasmania, Australia.
  • Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia.
  • Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.
  • University of Oxford, Oxford, UK.

ORCID-Profile: Darren C Henstridge

Förderung

  • Shine on Foundation
  • Diabetes Australia Research Trust

Zitieren

APA

Yew, M. J., Heywood, S. E., Ng, J., West, O. M., Pal, M., Kueh, A., Lancaster, G. I., Myers, S., Yang, C., Liu, Y., Reibe, S., Mellett, N. A., Meikle, P. J., Febbraio, M. A., Greening, D. W., Drew, B. G., & Henstridge, D. C. (2024). ACAD10 is not required for metformin's metabolic actions or for maintenance of whole‐body metabolism in C57BL / 6J mice. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15484

Vancouver

Yew MJ, Heywood SE, Ng J, West OM, Pal M, Kueh A, et al. ACAD10 is not required for metformin's metabolic actions or for maintenance of whole‐body metabolism in C57BL / 6J mice. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15484

BibTeX
@article{Yew2024,
  author = {Yew, Michael J and Heywood, Sarah E and Ng, Joe and West, Olivia M and Pal, Martin and Kueh, Andrew and Lancaster, Graeme I and Myers, Stephen and Yang, Christine and Liu, Yingying and Reibe, Saskia and Mellett, Natalie A and Meikle, Peter J and Febbraio, Mark A and Greening, David W and Drew, Brian G and Henstridge, Darren C},
  title = {ACAD10 is not required for metformin's metabolic actions or for maintenance of whole‐body metabolism in C57BL / 6J mice},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15484}
}
Kostenlos starten →